Ray Therapeutics
USEntry
2021
Hold
5yr
Status
Active
Who owns Ray Therapeutics?
Ray Therapeutics is currently owned by 4Bio Partners through 4BIO Ventures III (2022 vintage), since 2021. Across its history, Ray Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-07-08
Most recent investor
4Bio Partners4BIO Ventures III · 2022 · Life Sciences VC
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2021 · present
4Bio PartnersActive
2021 · present(5yr) · 4BIO Ventures III · 2022 · Life Sciences VC
Novo HoldingsActive
2023 · present(3yr) · Novo Holdings Venture Investments · 1999 · VC
More from 4BIO Ventures III
Other portfolio companies in the same fund.
UK
Switzerland
More PE-backed in Biotech
Comparable biotech deals from other GPs.
FranceTrack Ray Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Ray Therapeutics?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Ray Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue